Search Results 351-360 of 3740 for 搜索痕迹咨询邮箱：lgooxc@hotmail.com
The goal of Kelly D. Flemming, M.D., is to further elucidate the clinical outcomes in patients with cavernous malformations of the brain. How these lesions ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
In this study the investigators propose to use a daily dose of 45 mg (30 mg at 8 AM and 15 mg at 4 PM). This relatively small well-tolerated dose is likely to ...
View past members of Mayo Clinic's Bone Injury and Repair Lab led by Abhishek Chandra, Ph.D., M.S..
This is a study to evaluate the safety of MRX34 in patients with primary liver cancer or those with liver metastasis from other cancers. The drug is given ...
Surgery, chemotherapy drugs (cancer fighting medicines), and when necessary liver transplant are the main current treatments for hepatoblastoma. The stage of ...
The purpose of this study is to collect natural history and treatment-related data of patients diagnosed with congenital disorders of glycosylation.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.